Longevity Health Inc. (XAGE) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Longevity Health Inc.

NASDAQ: XAGE · Real-Time Price · USD
2.71
-0.02 (-0.73%)
At close: Aug 28, 2025, 11:42 AM

Longevity Health Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.8M -15.45M -9.05M -6.48M
Depreciation & Amortization
197.26K 124.79K 242.56K 242.12K
Stock-Based Compensation
827.04K 667.68K 636.37K 246.8K
Other Working Capital
1.24M -2.97M 1.28M 872.37K
Other Non-Cash Items
5.72M 9.73M 2.22M 1.35M
Deferred Income Tax
n/a n/a -194.59K 2.52M
Change in Working Capital
669.49K -3.42M 2.34M 952.69K
Operating Cash Flow
-4.39M -8.35M -3.81M -1.18M
Capital Expenditures
n/a -30.47K -7.16K -7.27K
Cash Acquisitions
-748.8K n/a n/a n/a
Purchase of Investments
n/a n/a n/a -154.44M
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 154.44M
Investing Cash Flow
-748.8K -30.47K -7.16K -7.27K
Debt Repayment
-218.49K -3.2M 2.75M 1.12M
Common Stock Repurchased
n/a n/a -2.29K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-86.31K 14.32M 125.88K 67.82K
Financial Cash Flow
2.38M 11.16M 3.93M 1.2M
Net Cash Flow
-2.76M 2.78M 115.79K 11.21K
Free Cash Flow
-4.39M -8.38M -3.44M -1.18M